Sophie Winder-Rhodes
Overview
Explore the profile of Sophie Winder-Rhodes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
758
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Szwedo A, Dalen I, Pedersen K, Camacho M, Backstrom D, Forsgren L, et al.
Mov Disord
. 2022 Feb;
37(5):1016-1027.
PMID: 35106798
Background: Common genetic variance in apolipoprotein E (APOE), β-glucocerebrosidase (GBA), microtubule-associated protein tau (MAPT), and α-synuclein (SNCA) has been linked to cognitive decline in Parkinson's disease (PD), although studies have...
2.
Stoker T, Camacho M, Winder-Rhodes S, Liu G, Scherzer C, Foltynie T, et al.
J Neurol Neurosurg Psychiatry
. 2020 Apr;
91(7):695-702.
PMID: 32303560
Introduction: Variants in the gene have been identified as a common risk factor for Parkinson's disease (PD). In addition to pathogenic mutations (those associated with Gaucher disease), a number of...
3.
Stoker T, Camacho M, Winder-Rhodes S, Liu G, Scherzer C, Foltynie T, et al.
J Neurol Neurosurg Psychiatry
. 2020 Apr;
91(6):673-674.
PMID: 32241921
No abstract available.
4.
Kim H, Mason S, Foltynie T, Winder-Rhodes S, Barker R, Williams-Gray C
Mov Disord
. 2020 Jan;
35(1):185-190.
PMID: 31965629
Background: Long-term population-representative data on motor fluctuations and levodopa-induced dyskinesias in Parkinson's disease is lacking. Methods: The Cambridgeshire Parkinson's Incidence from GP to Neurologist (CamPaIGN) cohort comprises incident PD cases...
5.
Winder-Rhodes S, Lotay R, Doyle J
J Intensive Care Soc
. 2017 Nov;
18(3):261-262.
PMID: 29118845
No abstract available.
6.
Liu G, Locascio J, Corvol J, Boot B, Liao Z, Page K, et al.
Lancet Neurol
. 2017 Jun;
16(8):620-629.
PMID: 28629879
Background: Cognitive decline is a debilitating manifestation of disease progression in Parkinson's disease. We aimed to develop a clinical-genetic score to predict global cognitive impairment in patients with the disease....
7.
Liu G, Boot B, Locascio J, Jansen I, Winder-Rhodes S, Eberly S, et al.
Ann Neurol
. 2016 Oct;
80(5):674-685.
PMID: 27717005
Objective: We hypothesized that specific mutations in the β-glucocerebrosidase gene (GBA) causing neuropathic Gaucher's disease (GD) in homozygotes lead to aggressive cognitive decline in heterozygous Parkinson's disease (PD) patients, whereas...
8.
Vuono R, Winder-Rhodes S, de Silva R, Cisbani G, Drouin-Ouellet J, Spillantini M, et al.
Brain
. 2015 May;
138(Pt 7):1907-18.
PMID: 25953777
Huntington's disease is a neurodegenerative disorder caused by an abnormal CAG repeat expansion within exon 1 of the huntingtin gene HTT. While several genetic modifiers, distinct from the Huntington's disease...
9.
Yarnall A, Breen D, Duncan G, Khoo T, Coleman S, Firbank M, et al.
Neurology
. 2013 Dec;
82(4):308-16.
PMID: 24363137
Objective: To describe the frequency of mild cognitive impairment (MCI) in Parkinson disease (PD) in a cohort of newly diagnosed incident PD cases and the associations with a panel of...
10.
Hudson G, Nalls M, Evans J, Breen D, Winder-Rhodes S, Morrison K, et al.
Neurology
. 2013 May;
80(22):2042-8.
PMID: 23645593
Objectives: Previous associations between mitochondrial DNA (mtDNA) and idiopathic Parkinson disease (PD) have been inconsistent and contradictory. Our aim was to resolve these inconsistencies and determine whether mtDNA has a...